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Abnormal heart morphogenesis can result in congenital 
heart defects (CHDs) or inherited cardiomyopathies. Inap-
propriate gene expression [1, 2], expression of mutant gene 
products [3, 4], and exposure to cardiotoxic chemicals [5] 
or drugs [6] are all known to promote CHDs. The result-
ing structural defects (exemplified by heterotaxy, atrial and 
ventricular septal defects, noncompaction, etc.) render heart 
pump function inadequate. Nearly 1% of all newborns will 
have a structural heart defect [7], and the majority of these 
are severe enough to cause death in the absence of surgical 
and/or other palliative intervention. Inherited cardiomyopa-
thies (that is, abnormalities of the sarcomere) [8, 9] consti-
tute another important class of CHDs.
While much is known about the clinical sequelae of CHDs, 
in many cases, the underlying molecular etiology remains 
undefined. For example, visceral heterotaxy results from the 
loss of left–right patterning during early embryogenesis, when 
the cell and molecular signaling cascades, which normally 
regulate sidedness pattern formation, are well-established. 
However, the spectrum of cardiac defects in many heterotaxy 
models and within patients with heterotaxy is more severe 
than what would be anticipated from a simple breakdown 
of sidedness patterning. The molecular basis for this is not 
understood. Similarly, the anatomical and clinical sequelae 
resulting from anomalies in ventricular septation and papil-
lary muscle morphogenesis are well characterized. Moreover, 
multiple genes have been identified, which when dysregulated 
impact the development of these structures. How dysregulated 
gene expression mechanistically gives rise to these morpho-
genic defects is at best poorly understood. A similar case can 
be made for events that regulate maturation of the ventricular 
wall. Left ventricular noncompaction (LVNC) is recognized 
as a distinct form of cardiomyopathy, which results from a 
morphogenic defect. However, the molecular processes that 
underlie this defect are not well understood; understanding the 
underlying molecular mechanisms which give rise to LVNC 
is critical to effect improvements in diagnosis and care [10].
To promote interactions between clinical and basic sci-
entists working on CHDs, the Riley Heart Center at Riley 
Hospital for Children, Indiana University School of Medi-
cine, has organized a series of symposia focusing on vari-
ous aspects of cardiac development. Previous symposia were 
entitled “Growth and Morphogenesis of the Ventricular 
Wall” (2008), “Transcriptional Unification of Heart Mor-
phogenesis” (2009), “Cardiomyocyte Injury and Protec-
tion” (2010), and “Development of the Cardiac Conduc-
tion System and Arrhythmias” (2011). The proceedings of 
these symposia were published in special issues of Pediatric 
Cardiology. Several articles reviewing the topics discussed 
at the 5th Riley Heart Center Symposium (2017), entitled 
“Development and Repair of the Ventricle Wall,” are pub-
lished in the prior and this issue of Pediatric Cardiology. 
The 5th Riley Heart Center Symposium was held in Indian-
apolis, Indiana, on November 20, 2017.
The symposium faculty included 14 leading clinical and 
basic scientists from the United States, Germany, and The 
Netherlands. Sessions at the symposium focused on (1) the 
genetic regulation of cardiac development, (2) the role of 
cell polarity in ventricular wall morphogenesis, (3) the cell 
and molecular basis for arrhythmic cardiomyopathies, and 
(4) cell cycle-based interventions to promote myocardial 
regeneration. The articles provide a state of the art review of 
basic and clinical studies focused on the regulation and eval-
uation of ventricular wall growth in experimental animals 
and in man. It is hoped that these proceedings, as well as 
those from future Riley Heart Center Symposia, will foster 
collaborative projects between clinical and basic researchers 
who are dedicated to improving the treatment, and ultimately 
preventing the onset, of heart failure in the young.
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